Among people who die from diseases in the world, deaths caused by atherosclerotic cardiovascular disease rank at the forefront. One of the important pathogenic risk factors in the development of atherosclerotic cardiovascular disease is dyslipidemia. Therefore, lipid-lowering drugs play an important role in preventing and controlling atherosclerotic cardiovascular disease.What...
Friday, October 13, 2023
The latest article ヽ( ・◇・)ノ
An introduction to Nivolumab (Opdivo®) and its common usage and dosage.(Part 2)👀👀👀
The introduction to Nivolumab (Opdivo®) Part. 2. Nivolumab is recommended for the treatment of a variety of malignancies in children aged 12...